Avidity Biosciences, Inc.
Avidity Biosciences, Inc. (RNA) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 231 transactions totaling $119.1M, demonstrating a bearish sentiment with -$45.3M in net insider flow. The most recent transaction on Jan 21, 2026 involved a sale of 1,758 shares valued at $127.4K.
RNA Insider Activity Summary
Who Is Buying RNA Stock?
No significant insider buying has been recorded for RNA in the recent period.
Who Is Selling RNA Stock?
No significant insider selling has been recorded for RNA in the recent period.
Is Avidity Biosciences, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RNA is bearish with an Insider Alignment Score of 31/100 and a net flow of -$45.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
RNA Frequently Asked Questions
Understanding RNA Insider Activity
Insider trading at Avidity Biosciences, Inc. (RNA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading RNA stock, having executed 231 transactions in the past 90 days. The most active insider is Sarah Boyce (Executive), who has made 50 transactions totaling $31.2M.
Related Tools
Track Avidity Biosciences, Inc. Insider Activity
Get notified when executives and directors at RNA file new Form 4 transactions